SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Bioequivalence and other unresolved issues in generic drug substitution
0 references·8 citing·24 second hop
Bioequivalence and other unresolved issues in generic drug substitution (2003)Bioequivalence and other unresolved issue…The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China (2020)The Impacts of National Centr…Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984 (2013)Development of the generic dr…An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland (2010)An evaluation of consumers’ k…Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post‐marketing clinical study on healthy volunteers (2009)Lack of pharmacokinetic bioeq…What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice (2007)What’s in a Name? Use of Bran…Current approaches to the use of generic antiepileptic drugs (2007)Current approaches to the use…Patients’ attitudes towards and experiences of generic drug substitution in Norway (2006)Patients’ attitudes towards a…Are there potential problems with generic substitution of antiepileptic drugs? (2006)Are there potential problems …Encouraging the use of generic medicines: implications for transition economies. (2002)The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs (2003)25-year Trends and Socio-demographic Differences in Response Rates: Finnish Adult Health Behaviour Survey (2006)Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand (2010)Demand-side policies to encourage the use of generic medicines: an overview (2013)Potential Clinical and Economic Impact of Switching Branded Medications to Generics (2015)Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Innovation Policy and the Economy (2007)Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Assessment [RETIRED] (1990)Clinical consequences of generic substitution of lamotrigine for patients with epilepsy (2008)Generic substitution in the treatment of epilepsy: Patient and physician perceptions (2008)CLINICAL CONSEQUENCES OF GENERIC SUBSTITUTION OF LAMOTRIGINE FOR PATIENTS WITH EPILEPSY (2009)Therapeutic equivalency of generic antiepileptic drugs: results of a survey (2004)Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals (1988)Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. (2002)Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000 (2005)Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending (2017)Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis (2021)A systematic review of pooled procurement of medicines and vaccines: identifying elements of success (2022)Impact of ‘4+7’ volume-based drug procurement on the use of policy-related original and generic drugs: a natural experimental study in China (2022)Competition in off-patent drug markets: Issues, regulation and evidence (2008)Consumers' views on generic medicines: A review of the literature (2009)Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications (2010)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2006Patients’ attitudes towards and experiences of generic drug substitution in Norway153 cited
  • 2006Are there potential problems with generic substitution of antiepileptic drugs?141 cited
  • 2010An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland110 cited
  • 2020The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China94 cited
  • 2007What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice79 cited
  • 2013Development of the generic drug industry in the US after the Hatch-Waxman Act of 198474 cited
  • 2009Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post‐marketing clinical study on healthy volunteers64 cited
  • 2007Current approaches to the use of generic antiepileptic drugs64 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work